When a person is diagnosed with multiple myeloma, their healthcare team conducts additional tests to determine the cancer's stage. Staging is essential for developing an effective treatment plan and ...

And stage IV means it's spread throughout the whole body. Multiple myeloma staging is completely different, because from the beginning, those plasma cells are basically in all the bones for most ...

which was approved by the FDA as a fourth-line or later option for multiple myeloma therapy earlier this year based on the CARTITUDE-1 data. Despite reaching the market around a year after Abecma ...

It makes up about 1.8% of all new cancer cases each year and about 10% of all blood cancers. You may not experience symptoms of multiple myeloma in the precancerous and early stages. If your ...

Treating late stage myeloma has multiple challenges. First of all, patients are usually more refractory to the most commonly used agents. And we know from old cohorts that if we see patients ...

The disease develops from asymptomatic precursor stages, monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM), with a subset of patients progressing from ...

Out of every 100 people with MGUS, each year, 1 or 2 of them will get cancer from MGUS ... There may be a link to autoimmune diseases, genetics, or environmental factors. Like multiple myeloma, MGUS ...

A stem cell transplant can be a good treatment for multiple myeloma. A successful transplant gives someone ... bone marrow transplant at MSK had a much higher predicted rate of 1-year survival. MSK ...

in adult patients with relapsed or refractory multiple myeloma. The trial demonstrated that Sarclisa SC, in combination with pomalidomide and dexamethasone (Pd), met its co-primary endpoints of ...